1. Yan, X., Yeh, C., and Zou, L. Clinical Applications of Circulating Tumor DNA, Circulating Tumor Cells, and Exosomes as Liquid Biopsy-Based Tumor Biomarkers[J]. Journal of Applied Bioanalysis, Volume 6, No. 3, August 2020.
2. Zhang, X., Zhang, Z., Shao, W., Lin Z., and Zou, L. A Review on LBA and LC-MS Platforms for Supporting Large Molecule Pharmacokinetics Bioanalysis[J]. Journal of Bioanalysis and Biomedicine, DOI: 10.37421/jbabms.2020.12.227, Volume 12:3, 2020.
3. Zhong, Z.D., Jiang, L., Khandelwal, P., Clarke, A.W., Bakhtiar, R., Zou, L. Development and Utility of an ELISA Method for Sensitive and Specific Detection of IgE Antidrug Antibodies[J]. The AAPS Journal. volume 22, Article number: 36, 2020.
4. Zou, L. and Nock S. Immunogenicity assessment of PEGylated proteins, Lonquex, a PEGylated G-CSF case study[J]. Book title: Polymer-Protein Conjugates. Elsevier, ISBN: 9780444640819, 2019.
5. Federman, N, Dragomir, MD, Kizyma, Z, Roganovic, J, Bias, P, Lammerich, A, Ben Arie, ZR, Zou, L, Hoehn G, Buchner A. A Phase 2, International, Multicenter, Open-label Clinical Trial of Subcutaneous Tbo-Filgrastim in Pediatric Patients with Solid Tumors Undergoing Myelosuppressive Chemotherapy[J]. Journal of Pediatric Hematology/Oncology. 41: 525-531, 2019.
6. Zou, L., Buchner, A., Field, F., Barash, S. and and Liu, P.M. Immunogenicity Assessment of Tbo-Filgrastim in Cancer Patients Receiving Chemotherapy[J]. Bioanalysis 10: 1221-1228, 2018.
7. Gupta, S., Richards, S., Amaravadi, L., Piccoli, S.,Desilva, B., Pillutla, R., Stevenson, L., Mehta, D., Carrasco-Triguero, M., Neely, R., Partridge,M., Staack, R.F., Zhao, X., Gorovits, B., Kolaitis, G., Sumner, G., Stubenrauch, K., Zou, L., et al. 2017 White Paper on Recent Issues in Bioanalysis: A Global Perspective on Immunogenicity Guidelines & Biomarker Assays Performance (Part 3 – LBA: Immunogenicity, Biomarkers and PK Assays) [J]. Bioanalysis 9: 1967-1996, 2017.
8. Marc-Olivier, M., Zou, L., Faust, H., Abdolzade-Bavil, A., Liu, P.M. Petra Struwe, P. Method establishment for discerned immunogenicity assessment of a recombinant glycoprotein containing nonhuman sialic acid Neu5Gc residues[J]. Bioanalysis 9: 1385–1393, 2017.
9. Zou, L., Buchner, A., Roberge M., and Liu, P.M. Immunogenicity assessment of lipegfilgrastim in patients with breast cancer receiving chemotherapy[J]. Journal of Immunology Research 23; 2016: 9248061. Epub 2016 Dec 23.
10. Liu, P.M., Zou, L., Sadhu, C., Shen W.D., and Nock, S. Comparative immunogenicity assessment: a critical consideration for biosimilar development (Invited Review) [J]. Bioanalysis 7: 373–381, 2015.
11. Liu, P.M., Handl, H., Zou, L., and Kim, B. Immunobiological aspects of therapeutic antibodies and related characterization approaches (Invited review) [J]. Current Opinion in Drug Discovery & Development 10: 515-522, 2007.
12. Chen, Q., Long, Y., Yuan, X., Zou, L., Sun J., Chen S., Perez-Polo J.R., Yang K. Protective effects of bone marrow stromal cell transplantation in injured rodent brain: synthesis of neurotrophic factors[J]. Journal of Neuroscience Research 80: 611-619, 2005.
13. Long, Y., Zou, L., Liu, H., Lu, H., Yuan, X.Q., Robertson, C.S., and Yang, K. Altered expression of randomly selected genes in mouse hippocampus after traumatic brain injury[J]. Journal of Neuroscience Research 71: 710-720, 2003.
14. Zou, L., Yuan, X.Q., Long, Y., Shine, H.D., and Yang, K. Improvement of cognitive function after adenovirus-mediated transfer of nerve growth factor gene to aged rat brain[J]. Human Gene Therapy 13: 2173-2184, 2002.
15. Zou, L., Yotnda, P., Zhao, T., Yuan, X., Long, Y., Zhou, H., and Yang, K. Reduced inflammatory reactions to the inoculation of helper-dependent adenoviral vectors in traumatically injured rat brain[J]. Journal of Cerebral Blood Flow and Metabolism 22: 959-970, 2002.
16. Kumar, A., Zou, L., Yuan, X.Q., Long, Y., and Yang, K. NMDA receptors: transient loss of NR1/NR2A/NR2B subunits after traumatic brain injury in a rodent model[J]. Journal of Neuroscience Research 67: 781-786, 2002.
17. Zou, L., Yuan, X., Zhou, H., Lu, H., and Yang, K. Helper-dependent adenoviral vector (hdAdv)-mediated gene transfer in aged rat brain[J]. Human Gene Therapy 12: 181-191, 2001.
18. Zou, L., Zhou, H., Pastore, L., and Yang, K. Prolonged transgene expression mediated by a helper-dependent adenoviral vector (hdAdv) in the central nervous system[J]. Molecular Therapy 2: 105-113, 2000.
19. Xu F.J., Xia W.Y., Luo R.Z., Peng H.Q., Zhao S.L., Dai J.Y., Long Y., Zou, L., Le W.D., Liu J.S., Parlow A.F., Hung MC., Bast RC, Jr., and Yu YH. The human ARHI tumor suppressor gene inhibits lactation and growth in transgenic mice[J]. Cancer Research 60: 4913-4920, 2000.
20. Mohamed, H.A., Mosier, D., Zou, L., Siklos, L., Alexianu, M., Engelhardt, J., Beers, D.R., Le, W., and Appel, S.H. Immunoglobulin Fc gamma receptor promotes immunoglobulin uptake, immunoglobulin-mediated calcium increase, and neurotransmitter release in motor neurons[J]. Journal of Neuroscience Research 69: 110-116, 2002.
21. Zou, L., Xu, J., Jankovic, J., He, Y., Appel S.H., and Le, W. D. Pramipexole inhibits lipid peroxidation and reduces MPTP-induced nigral injury in C57BL/6 mice[J]. Neuroscience Letter 281: 167-170, 2000.
22. Zou, L., Huang, L., Hayes, R.L., Black, C., Qiu, Y.H., Perez-Polo, J.R., Le, W., Clifton, G.L., and Yang, K. Liposome-mediated NGF gene transfection following neuronal injury: Potential therapeutic applications[J]. Gene Therapy 6: 994-1005, 1999.
23. Zou, L., Jankovic, J., Rowe, D.B., Xie, W.J., Appel, S.H., and Le, W.D. Neuroprotection by pramipexole against dopamine- and levodopa-induced neurotoxicity[J]. Life Science 64: 1275-1285, 1999.
24. Le W.D., Conneely OM, Zou, L., He Y, Saucedo-Cardenas O, Jankovic J, Mosier DR, and Appel SH. Selective agenesis of mesencephalic dopaminergic neurons in Nurr1-deficient mice[J]. Experimental Neurology 159: 451-458, 1999.
25. Zou, L., Lu, H., Coleman, M., Abruzzese, R., Nordstrom, J., Wang, J., Ozol, K., Hayes, R., and Yang, K. Liposome mediated RU486-regulated gene transfer in CNS cell and tissue: potential in gene therapy for traumatic brain injury[J]. Journal of Neurotrauma 16: 1006, 1999.
26. Guo, X., Zou, L., and Jin, G.Z. D1/D2 interaction in membrane abolished by 6-OHDA lesion[J]. Life Science 63: PL7-PL13, 1998.
27. Guo, X., Liu, J., Zou, L., Jin, J, Wang, B.C., and Jin, G.Z. Enhancement of (-) -stepholidine on protein phosphorylation of a dopamine- and cAMP-regulated phosphoprotein in denervated striatum of oxidopamine-lesioned rats[J]. Acta Pharmacology Sinica 19: 100-104, 1998.
28. Zou, L., Liu, J., and Jin, G.Z. Involvement of receptor reserve in D1 agonistic action of (-)-stepholidine in lesioned rats[J]. Biochemical Pharmacology 54: 233-240, 1997.
29. Zou, L., Chen, Y., Song, Y., and Jin, G.Z. Effect of (-)-stepholidine on serum prolactin level of female rats[J]. Acta Pharmacology Sinica 17: 311-314, 1996.
30. Zou, L., Cai, S., and Jin, G.Z. Chronic treatment with (-)-stepholidine alters the density and turnover of striatal D1 and D2 receptors[J]. Acta Pharmacology Sinica 17: 485-489, 1996.
